发明授权
- 专利标题： Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
- 专利标题（中）： 可用于治疗退行性和炎性疾病的三唑并吡嗪化合物
-
申请号： US12399979申请日： 2009-03-08
-
公开(公告)号： US07915256B2公开(公告)日： 2011-03-29
- 发明人: Martin James Inglis Andrews , Paul Edwards , Mark Stuart Chambers , Wolfgang Schmidt , Juha Andrew Clase , Gregory Bar , Kim Louise Hirst , Angus MacLeod
- 申请人： Martin James Inglis Andrews , Paul Edwards , Mark Stuart Chambers , Wolfgang Schmidt , Juha Andrew Clase , Gregory Bar , Kim Louise Hirst , Angus MacLeod
- 申请人地址： BE Mechelen
- 专利权人： Galapagos NV
- 当前专利权人： Galapagos NV
- 当前专利权人地址： BE Mechelen
- 代理机构： Klauber & Jackson LLC
- 主分类号： C07D403/12
- IPC分类号： C07D403/12 ; A61K31/506
摘要：
Novel [1.2.4]triazolo[1,5-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
公开/授权文献
信息查询
